| Contrast Enhanced Ultrasonography to Detect Human Renal Transplant Rejection (NCT02733029) | Brigham and Women's Hospital | 2018-05-30 |
| To Compare the Pulpal Oxygen Saturation Level After Administering Mepivacaine With and Without Vasoconstrictor (NCT04947267) | Afshan Amjad Ali | 2018-05-30 |
| PF-06741086 Long-term Treatment in Severe Hemophilia (NCT03363321) | Pfizer | 2018-05-30 |
| Safety and Immunogenicity of Venezuelan Equine Encephalomyelitis Vaccine in Healthy Adults (NCT03051386) | U.S. Army Medical Research and Development Command | 2018-05-30 |
| ACES - ACE Inhibitors Combined With Exercise for Seniors With Hypertension (NCT03295734) | University of Alabama at Birmingham | 2018-05-29 |
| An Efficacy Trial of Low Dose All-trans Retinoic Acid in Patients With Primary Sclerosing Cholangitis (NCT03359174) | Yale University | 2018-05-29 |
| Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer (NCT03567629) | Peking University | 2018-05-29 |
| Investigation of Sleep in the Intensive Care Unit (NCT03355053) | Massachusetts General Hospital | 2018-05-29 |
| Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer (NCT03490292) | University of Wisconsin, Madison | 2018-05-29 |
| METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin (NCT03388190) | University Hospital, Akershus | 2018-05-29 |
| A Study of REGN2810 and Ipilimumab in Patients With Lung Cancer (NCT03430063) | Regeneron Pharmaceuticals | 2018-05-29 |
| Rapid Agitation Control With Ketamine in the Emergency Department (NCT03375671) | David Barbic | 2018-05-29 |
| Necitumumab in the Neoadjuvant Setting With Gemcitabine in Surgically Resectable - 14X-US-I001 (NCT03574818) | Montefiore Medical Center | 2018-05-29 |
| Phase II Trial of Nivolumab Plus Ipilimumab in Patients With Renal Medullary Carcinoma (NCT03274258) | M.D. Anderson Cancer Center | 2018-05-29 |
| SHR-1210 in Patients With Relapsed or Refractory Extranodal NK/T Cell Lymphoma (NCT03363555) | Jiangsu HengRui Medicine Co., Ltd. | 2018-05-29 |
| To Evaluate the Efficacy and Safety of LuminoMark Injection in Patients With Nonpalpable Breast Lesions (NCT03743259) | Hanlim Pharm. Co., Ltd. | 2018-05-29 |
| A Study of Oral BTD-001 in Adults With Idiopathic Hypersomnia (NCT03542851) | Balance Therapeutics | 2018-05-29 |
| A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus (NCT03467932) | Oramed, Ltd. | 2018-05-29 |
| Effect of Over-the-counter Toothpastes on Chemotherapy-induced Oral Mucositis (NCT02606994) | Oral Defense, LLC | 2018-05-29 |
| The Clinical Trial to Evaluate the Efficacy and Safety of CKD-497 (NCT03726853) | Chong Kun Dang Pharmaceutical | 2018-05-29 |
| Repeat Doses of BAY1902607 in Healthy Males and Proof of Concept in Chronic Cough Patients (NCT03535168) | Bayer | 2018-05-29 |
| INhalation of Flecainide to Convert Recent Onset SympTomatic Atrial Fibrillation to siNus rhyThm (INSTANT) (NCT03539302) | InCarda Therapeutics, Inc. | 2018-05-29 |
| Pembrolizumab and Radiation Therapy in Patients With Relapsed or Refractory Multiple Myeloma (NCT03267888) | Emory University | 2018-05-29 |
| Safety and Efficacy of "Immuncell-LC" in TACE Therapy (NCT02856815) | GC Cell Corporation | 2018-05-28 |
| Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (NCT02969083) | The European Uro-Oncology Group | 2018-05-28 |
| Radiation-protection Effect of Amifostine in Locally Advanced Rectal Cancer (NCT03702985) | Fudan University | 2018-05-28 |
| Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC (NCT03410615) | Canadian Cancer Trials Group | 2018-05-28 |
| Durability Extension Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Stress Urinary Incontinence (NCT03508648) | GTx | 2018-05-28 |
| Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma (NCT03313206) | Gustave Roussy, Cancer Campus, Grand Paris | 2018-05-28 |
| Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer (NCT03545711) | Chinese Academy of Medical Sciences | 2018-05-26 |
| QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) Vaccine (NCT03563170) | ImmunityBio, Inc. | 2018-05-25 |
| Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant (NCT03289299) | International Myeloma Foundation | 2018-05-25 |
| Feasibility and Safety of Nintedanib in Combination With Nivolumab in Pretreated Patients With Advanced or Metastatic NSCLC of Adenocarcinoma Histology (NCT04046614) | AIO-Studien-gGmbH | 2018-05-25 |
| Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis (NCT03478605) | Blokhin's Russian Cancer Research Center | 2018-05-25 |
| PINIT Study: Primary Intranasal Insulin Trial (NCT03182322) | Technical University of Munich | 2018-05-25 |
| Evaluation of a Subcutaneous Progestogen Implants in the Medical Management of Painful Endometriosis (NCT02669238) | Centre Hospitalier Universitaire de la Réunion | 2018-05-25 |
| A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD) (NCT03539549) | Allergan | 2018-05-25 |
| Tocilizumab for Cytokine Release Syndrome Prophylaxis in Haploidentical Transplantation (NCT03533101) | Hospital Universitario Dr. Jose E. Gonzalez | 2018-05-25 |
| A Study to Evaluate the Safety and Immunogenecity of LBVE(Multivalent Pneumococcal Conjugate Vaccine) in Healthy Infants (NCT03467984) | LG Chem | 2018-05-25 |
| A Study Of The Selective PKC-β Inhibitor MS- 553 (NCT03492125) | MingSight Pharmaceuticals, Inc | 2018-05-25 |
| BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes (NCT03432897) | Brown University | 2018-05-25 |
| A Clinical Safety and Efficacy Study of Mebendazole on GI Cancer or Cancer of Unknown Origin. (NCT03628079) | Repos Pharma | 2018-05-25 |
| High Dose IL 2 and Entinostat in RCC (NCT03501381) | Roberto Pili | 2018-05-24 |
| INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma (NCT03502785) | Inovio Pharmaceuticals | 2018-05-24 |
| Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus (NCT02995005) | Johns Hopkins Bloomberg School of Public Health | 2018-05-24 |
| A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II) (NCT03198949) | Yonsei University | 2018-05-24 |
| Effect of Metformin on Frailty in 12 Subjects (NCT03451006) | Mayo Clinic | 2018-05-24 |
| Ixekizumab in the Treatment of Pityriasis Rubra Pilaris (PRP) (NCT03485976) | Oregon Health and Science University | 2018-05-23 |
| Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement (NCT03531294) | Greater Houston Retina Research | 2018-05-23 |
| Mineralocorticoid Antagonism to Stop Progression of Atrial Fibrillation (MONITOR-AF) Study (NCT04327232) | National University Hospital, Singapore | 2018-05-23 |
| Effect of Blinatumomab on Minimal Residual Disease (MRD) in Diffuse Large B-Cell Lymphoma (DLBCL) Subjects Post Autologous Hematopoietic Stem Cell Transplantation (aHSCT) (NCT03298412) | Amgen | 2018-05-23 |
| A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer (NCT03514836) | SOTIO a.s. | 2018-05-23 |
| Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C) (NCT03271255) | Shenzhen People's Hospital | 2018-05-23 |
| Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk (NCT03436862) | SCRI Development Innovations, LLC | 2018-05-23 |
| Pembrolizumab in First Line Treatment of Advanced NSCLC Patients With PD-L1 Low Tumors. (NCT03447678) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2018-05-23 |
| ENERGI-F701 for Female Hair Loss Treatment (NCT03351322) | Energenesis Biomedical Co., Ltd. | 2018-05-23 |
| Ibrutinib as Early Therapy in Chronic Lymphocytic Leukemia (CLL) (NCT03207555) | M.D. Anderson Cancer Center | 2018-05-23 |
| Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis (NCT03538951) | Vidac Pharma | 2018-05-23 |
| 68Ga-PSMA-R2 in Patients With Biochemical Relapse (BR) and Metastatic Prostate Cancer (mPCa) (NCT03490032) | Advanced Accelerator Applications | 2018-05-23 |
| Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS (NCT03567577) | Apeptico Forschung und Entwicklung GmbH | 2018-05-23 |
| A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors (NCT04539496) | Sihuan Pharmaceutical Holdings Group Ltd. | 2018-05-22 |
| MTX110 by Convection-Enhanced Delivery in Treating Participants With Newly-Diagnosed Diffuse Intrinsic Pontine Glioma (NCT03566199) | Sabine Mueller, MD, PhD | 2018-05-22 |
| Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis (NCT03410056) | Amgen | 2018-05-22 |
| DMT310-001 Topical in the Treatment of Acne Vulgaris (NCT03536637) | Dermata Therapeutics | 2018-05-22 |
| Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction (NCT03549260) | LIB Therapeutics LLC | 2018-05-22 |
| A Trial of CXD101 in Combination With Nivolumab in Patients With Metastatic Microsatellite-Stable Colorectal Cancer (NCT03993626) | Celleron Therapeutics Ltd. | 2018-05-22 |
| A Study of CS1001 in Subjects With Relapsed or Refractory Classical Hodgkin Lymphoma (NCT03505996) | CStone Pharmaceuticals | 2018-05-22 |
| Accessing Mobility Using Wearable Sensors (NCT04306588) | Baylor College of Medicine | 2018-05-21 |
| Walnuts to Achieve Lasting NUTrition to Prevent Diabetes (NCT03334175) | University of California, San Francisco | 2018-05-21 |
| Efficacy of Oral Vancomycin Prophylaxis for Prevention of Recurrent Clostridium Difficile Infection (NCT03462459) | University of Wisconsin, Madison | 2018-05-21 |
| Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM (NCT03452579) | David Peereboom | 2018-05-21 |
| DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer (NCT03505710) | Daiichi Sankyo | 2018-05-21 |
| Individualized Adaptive De-escalated Radiotherapy for HPV-related Oropharynx Cancer (NCT03416153) | University of Michigan Rogel Cancer Center | 2018-05-21 |
| A Phase II Study of Bermekimab (MABp1) in Patients With Moderate to Severe Atopic Dermatitis (NCT03496974) | Janssen Research & Development, LLC | 2018-05-21 |
| Cisplatin/Carboplatin and Etoposide With or Without Nivolumab in Treating Patients With Extensive Stage Small Cell Lung Cancer (NCT03382561) | National Cancer Institute (NCI) | 2018-05-21 |
| Feasibility and Acceptability of a Physical Activity Behavior Change Intervention for Parkinson's Disease (NCT03696589) | Teachers College, Columbia University | 2018-05-21 |
| Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC (NCT03417544) | Nancy Lin, MD | 2018-05-21 |
| Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer (NCT04425239) | National Cancer Institute, Naples | 2018-05-21 |
| Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers (NCT03564340) | Regeneron Pharmaceuticals | 2018-05-21 |
| OXEL: Immune Checkpoint or Capecitabine or Combination Therapy as Adjuvant Therapy for TNBC With Residual Disease (NCT03487666) | Georgetown University | 2018-05-21 |
| A First-in-Human Study of alpha1H in Patients With Non-muscle Invasive Bladder Cancer (NCT03560479) | Hamlet Pharma AB | 2018-05-21 |
| Intraarticular Injections of the Hip and Knee With Triamcinolone Versus Ketorolac: A Randomized Controlled Trial (NCT04441112) | Saint Alphonsus Regional Medical Center | 2018-05-20 |
| Evolocumab in Acute Coronary Syndrome (NCT03515304) | Johns Hopkins University | 2018-05-20 |
| Evaluation of Therapeutic Effect and Safety of Mifepristone in the Treatment of Adenomyosis (NCT03520439) | xinmei zhang | 2018-05-19 |
| PRecision Interventions for SMoking in the SCCS (NCT03521141) | Vanderbilt University Medical Center | 2018-05-18 |
| Redesigned Process in the Operating Room (NCT01937247) | American University of Beirut Medical Center | 2018-05-18 |
| International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia (NCT03705507) | University of Birmingham | 2018-05-18 |
| Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status (NCT03457896) | NSABP Foundation Inc | 2018-05-18 |
| Messenger RNA (mRNA)-Based, Personalized Cancer Vaccine Against Neoantigens Expressed by the Autologous Cancer (NCT03480152) | National Cancer Institute (NCI) | 2018-05-18 |
| N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy (NCT03499249) | Baylor College of Medicine | 2018-05-18 |
| Safety and Dose-Finding Study of DTX401 (AAV8G6PC) in Adults With Glycogen Storage Disease Type Ia (GSDIa) (NCT03517085) | Ultragenyx Pharmaceutical Inc | 2018-05-18 |
| Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486 (NCT03493646) | Kirby Institute | 2018-05-18 |
| Soluble Epoxide Hydrolase Inhibition and Insulin Resistance (NCT03486223) | Vanderbilt University Medical Center | 2018-05-17 |
| Cardiac Safe Transplants for Systemic Sclerosis (NCT03593902) | Northwestern University | 2018-05-17 |
| Evaluation of Efficacy and Safety of Subcutaneous Acetaminophen (NCT03635684) | Saint-Joseph University | 2018-05-17 |
| Levocarnitine and Vitamin B Complex in Treating PEG-Asparaginase or Inotuzumab Ozogamicin-Induced Hyperbilirubinemia in Patients With Acute Lymphoblastic Leukemia (NCT03564678) | M.D. Anderson Cancer Center | 2018-05-17 |
| A Study of CCX140-B in Subjects With FSGS (NCT03536754) | Amgen | 2018-05-17 |
| Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma (NCT03390595) | Associació per a la Recerca Oncologica, Spain | 2018-05-17 |
| M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas (NCT03451773) | National Cancer Institute (NCI) | 2018-05-17 |
| A Study of BNC210 in Elderly Patients With Agitation (NCT03548194) | Bionomics Limited | 2018-05-17 |